The supplemental New Drug Application seeks to expand the use of Ameluz with red light photodynamic therapy beyond the face and scalp to actinic keratoses on the extremities, neck, and trunk.
|Articles|May 1, 2017
Many areas of purple ecchymosis
An 82-year-old woman who loved to volunteer at her local botanical garden noticed that this past summer she had developed many areas of purple ecchymosis. She told her doctor that they seemed to appear mainly on her arms and hands, where the sun was most often blazing down on her, though she was diligent about using sunscreen these days. The only change she could think of from previous summers, when she hadn’t experienced such easy bruising, was that she had started taking daily aspirin at her doctor’s suggestion.
Advertisement
Used "Article web URL:" below
Advertisement
Related to this article
The 4-day CME meeting in Las Vegas offers up to 24.25 credits and sessions on inflammatory skin disease, skin cancer, pediatric dermatology, aesthetics, and more.
A biopsy-based analysis from the JADE MOA trial presented at EADV 2026 found reductions in pathogenic skin-resident memory T cells alongside restoration of epidermal barrier integrity.
The approval of the oral BTKi rests on a phase 3 result of 29.3% complete response from hives vs 14.0% with placebo at week 12.
This week’s review highlights pediatric oral minoxidil guidance, alopecia areata imaging, inherited skin disorder growth patterns, total-body photography, and radiofrequency microneedling for rosacea.
Celltrion’s US launch of omalizumab-igec adds an interchangeable biosimilar option for eligible patients with chronic spontaneous urticaria.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
Explore dermatology conferences and meetings taking place this October, including clinical updates, skin of color education, and pediatric dermatology research.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Remibrutinib for Symptomatic Dermographism
2
Abrocitinib Reduces Pathogenic Skin-Resident Memory T Cells in Atopic Dermatitis
3
Personalized Prescription Skin Care: Curology’s Whitney Tolpinrud, MD, on the Evolution of Virtual Dermatology
4
Previewing the 2026 Fall Clinical Dermatology Conference
5